Skip to main content

Table 1 Patient characteristics

From: Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer

Characteristics

Patients (n = 223)

Gender

 Male

134 (60%)

 Female

89 (40%)

Age

 < 65

67 (30%)

 ≥ 65

156 (70%)

Size

 < 5 cm

135 (61%)

 ≥ 5 cm

88 (39%)

Tumor location

 Left colon

102 (46%)

 Right colon

66 (30%)

 Rectum

55 (25%)

Histological type

 Adenocarcinoma

207 (93%)

 Others

16 (7%)

Differentiation

 Well/moderate

152 (68%)

 Poor

71 (32%)

Lymphovascular invasion

 Negative

115 (52%)

 Positive

108 (48%)

Perineural invasion

 Negative

40 (18%)

 Positive

183 (82%)

Harvested LNs

 < 12

82 (37%)

 ≥ 12

141 (63%)

pT category

 T1, T2

35 (16%)

 T3

77 (35%)

 T4

111 (50%)

pN category

 N0

125 (56%)

 N1

67 (30%)

 N2

31 (14%)

pTNM stage

 Stage I

25 (11%)

 Stage II

100 (45%)

 Stage III

98 (44%)

CEA

 Negative

132 (59%)

 Positive

91 (41%)

CA199

 Negative

179 (80%)

 Positive

44 (20%)

Cholesterol

 Low

20 (9%)

 High

203 (91%)

Triglyceride

 Low

182 (82%)

 High

41 (18%)

NLR

 Low

193 (86%)

 High

30 (14%)

CLR

 Low

134 (60%)

 High

89 (40%)

Recurrence

 No

167 (75%)

 Yes

56 (25%)

Survival

 Alive

176 (79%)

 Dead

47 (21%)

  1. Abbreviations: LNs Lymph nodes, CEA Carcinoembryonic antigen, NLR Neutrophil-to-lymphocyte ratio; CLR Cholesterol-to-lymphocyte ratio